Canadian Cancer Trials Group Bulletins

Trial Management Group

Trial Activation

The Canadian Cancer Trials Group is pleased to announce that Canadian Cancer Trials Group MAC.14 (E2108) -- A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer -- was centrally activated on 22 June 2011. This trial compares standard of care palliative local therapy vs complete local therapy involving resection plus radiotherapy for the intact primary tumour.

For more information, please contact the trial Study Coordinator, Eliot Frymire, at 613-533-6430 or